Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis.

ABSTRACT:

SUBMITTER: Haddox CL 

PROVIDER: S-EPMC5637108 | biostudies-literature | 2017 Sep

REPOSITORIES: biostudies-literature